يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Cristina Guarducci"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)

    المؤلفون: Stefania Vitale, Amelia McCartney, Luca Malorni, Serena Di Cosimo, Ilenia Migliaccio, Chiara Biagioni, Jens Huober, Angelo Di Leo, Dario Romagnoli, Cristina Guarducci, Giulia Boccalini, Matteo Benelli, Emanuela Risi, Florentine Hilbers, Christos Sotiriou, Martina Bonechi, Laura Biganzoli

    المصدر: Therapeutic Advances in Medical Oncology
    Therapeutic Advances in Medical Oncology, Vol 11 (2019)
    Therapeutic advances in medical oncology, 11

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Induktionstherapie, Lapatinib, lcsh:RC254-282, Trastuzumab, Internal medicine, medicine, gene expression profiling, Brustkrebs, In patient, ddc:610, predictive biomarker, RB pathway, Loss function, Original Research, Chemotherapy, business.industry, Médecine pathologie humaine, HER2+ breast cancer, Biomarker, Gene signature, Sciences bio-médicales et agricoles, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Gene expression profiling, Cancérologie, Genexpression, Neoadjuvant therapy, Gene expression, Anti her2, Breast neoplasms, business, DDC 610 / Medicine & health, Biomarkers, medicine.drug, neoadjuvant chemotherapy

    وصف الملف: application/pdf; 4 full-text file(s): application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c5a2f2a3160ba6079581c700d4cf26eTest


    أضف إلى المفضلة
  2. 2
    Challenges in the management of advanced, ER-positive, HER2-negative breast cancer

    المؤلفون: Luca Malorni, Laura Biganzoli, Angelo Di Leo, Ilenia Migliaccio, Cristina Guarducci, Christopher D. Hart

    المصدر: Nature Reviews Clinical Oncology. 12:541-552

    مصطلحات موضوعية: Oncology, Gynecology, medicine.medical_specialty, Everolimus, Antineoplastic Agents, Hormonal, Tumour heterogeneity, Receptor, ErbB-2, business.industry, HER2 negative, Breast Neoplasms, Context (language use), Disease, medicine.disease, Optimal management, Breast cancer, Receptors, Estrogen, Internal medicine, medicine, Humans, Female, Neoplasm Metastasis, Stage (cooking), business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2c19ee765e3234a62b7bbc65c7e4edTest
    https://doi.org/10.1038/nrclinonc.2015.99Test


    أضف إلى المفضلة
  3. 3
    Abstract S1-01: TransCONFIRM: The correlative analysis of breast tumors from patients with advanced hormone receptor positive disease identifies a genetic signature associated with decreased benefit from single agent fulvestrant

    المؤلفون: Rinath Jeselsohn, Cristina Guarducci, Eric P. Winer, Naomi Laing, Ilenia Migliaccio, Angelo Di Leo, Gilles Buchwalter, Luca Malorni, Chiara Biagioni, Jin Zhao, William T. Barry, Martina Bonechi, Myles Brown, Yuri Rukazenkov

    المصدر: Cancer Research. 75:S1-01

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Pathology, Fulvestrant, Proportional hazards model, business.industry, Cancer, Disease, medicine.disease, Breast cancer, Internal medicine, Cohort, medicine, Progression-free survival, Stage (cooking), business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bb1b7a34f15066c1da11e5453b6c468eTest
    https://doi.org/10.1158/1538-7445.sabcs14-s1-01Test


    أضف إلى المفضلة
  4. 4
    DNA repair metagene signature as a prognostic and predictive factor in molecular breast cancer subtypes

    المؤلفون: Martha R. Stampfer, William Fraser Symmans, Bianchini Giampaolo, Naoki Hayashi, Gabriel N. Hortobagyi, Lajos Pusztai, Libero Santarpia, Cristina Guarducci, Takayuki Iwamoto, Angelo Di Leo

    المصدر: Journal of Clinical Oncology. 30:1012-1012

    مصطلحات موضوعية: Cisplatin, Cancer Research, Pathology, medicine.medical_specialty, business.industry, DNA repair, medicine.disease, Gene expression profiling, Breast cancer, Oncology, XRCC3, Cancer research, Medicine, ERCC2, business, Gene, Pathological, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3641ee717b10cd54b9b1fc43594c66b9Test
    https://doi.org/10.1200/jco.2012.30.15_suppl.1012Test


    أضف إلى المفضلة
  5. 5
    Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

    المؤلفون: Angelo Di Leo, Christopher D. Hart, Cristina Guarducci, Ilenia Migliaccio, Luca Malorni

    المصدر: BMC Medicine

    مصطلحات موضوعية: Endocrine therapy, Oncology, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Receptor, ErbB-2, Breast Neoplasms, Review, Internal medicine, medicine, Humans, Endocrine system, Aromatase, Fulvestrant, HER2 negative breast cancer, Medicine(all), Estradiol, biology, Aromatase Inhibitors, business.industry, Cancer, General Medicine, Metastatic breast cancer, medicine.disease, ErbB Receptors, Postmenopause, Tamoxifen, Hormone receptor, biology.protein, Female, Hormone receptor positive breast cancer, business, medicine.drug, Hormone

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1847852e54d1f3dec29452b77d43d89bTest


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث